Who owns COLLEGIUM PHARMACEUTICAL, INC (COLL)? Elite investor 13F holders

5 tracked elite investors reported holding COLLEGIUM PHARMACEUTICAL, INC as of 2026-09-30, including Renaissance Technologies LLC, Rubric Capital, D.E. Shaw, Third Avenue Management, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Renaissance Technologies LLCCOLLEGIUM PHARMACEUTICAL INCSHARE2026-09-302026-11-12 00:00:0030731179.00 USD1408395.000000SharesaddOriginal filing
Rubric CapitalCOLLEGIUM PHARMACEUTICAL INCSHARE2026-09-302026-11-16 00:00:0013655371.00 USD625819.000000SharesreduceOriginal filing
D.E. ShawCOLLEGIUM PHARMACEUTICAL INCSHARE2026-09-302026-11-16 00:00:00975900.00 USD44725.000000SharesreduceOriginal filing
Third Avenue ManagementCOLLEGIUM PHARMACEUTICAL INCSHARE2026-09-302026-11-13 00:00:004860143.00 USD222738.000000SharesaddOriginal filing
Gotham Asset ManagementCOLLEGIUM PHARMACEUTICAL INCSHARE2026-09-302026-11-16 00:00:00652418.00 USD29900.000000SharesreduceOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown